Ranbaxy Plans New JV in China (India)
This article was originally published in PharmAsia News
Executive Summary
India's top pharmaceutical manufacturer Ranbaxy Laboratories has announced its intention to enter into a joint venture in China. According to representatives for Ranbaxy, it has approached two to three large Chinese manufacturers in search of the right match. If a deal goes through, Ranbaxy would work with these companies to turn out more active pharmaceutical ingredients (API) used in drug production. Currently, the majority of Ranbaxy's API is used for its own products. A China deal would allow Ranbaxy to improve its API capabilities. (Click here for more